Regencell Bioscience Holdings Limited Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited

RGC

Rank in Stocks #3563
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Share Price
$9.69
Last synced: 2026-10-16
Market Cap
$4.81B
Change (1 day)
1.79%
Change (1 year)
-44.34%
Country
HK
Trade Regencell Bioscience Holdings Limited (RGC)

Category

Healthcare
Operating Margin for Regencell Bioscience Holdings Limited (RGC)
Operating Margin as of October 2026 TTM: 0.00%
According to Regencell Bioscience Holdings Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2024 the company had an Operating Margin of 0.00%.
Operating Margin history for Regencell Bioscience Holdings Limited from 2019 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.